Parthenon Therapeutics
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- $40M
Investors
- 10
About Parthenon Therapeutics
Parthenon Therapeutics Inc.Founded in 2019 and headquartered in Cambridge, US, Parthenon Therapeutics Inc. specializes in the discovery and development of innovative cancer therapies. The company was established by C Begley, Laurent Audoly, Olga Granaturova, and Vito Quaranta, with Wendye Robbins serving as the CEO.Parthenon Therapeutics is engaged in the development of PRTH-101, a novel monoclonal antibody that targets Discoidin Domain Receptor 1 (DDR1) and aims to disrupt the tumor microenvironment (TME). This product is currently in a Phase 1c clinical trial for patients with immune checkpoint inhibitor-refractory thymic carcinoma. Their focus is on addressing barriers that hinder immune cell access in difficult cancer types, including pancreatic, ovarian, and colorectal cancers.Parthenon Therapeutics generates revenue through clinical research agreements and partnerships with pharmaceutical companies and healthcare institutions. Their collaborative model includes milestone payments linked to clinical trial phases and potential royalties on sales upon drug approval. The company is focused on expanding its product portfolio and aims to explore additional markets in North America and Europe as it progresses.
Who invested in Parthenon Therapeutics
10 investors across 1 round
See all investors in Parthenon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 13, 2021
Amount
$40M
Investors
Questions about Parthenon Therapeutics
Who invested in Parthenon Therapeutics?
Parthenon Therapeutics has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Parthenon Therapeutics raised?
Parthenon Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Parthenon Therapeutics last raise money?
Parthenon Therapeutics's most recent round on record is a Series A, in Aug 2021.
What does Parthenon Therapeutics do?
Parthenon Therapeutics is a biotechnology company.
Where is Parthenon Therapeutics headquartered?
Parthenon Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Parthenon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Parthenon Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Parthenon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.